相关实验视频

Updated: Jul 1, 2025

A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy
06:58

A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy

Published on: July 12, 2021

4.9K

帕尔瓦胺神经元中断导致SCN8A性脑病发作中的突触传输缺陷和发作

Raquel M Miralles, Alexis R Boscia, Shrinidhi Kittur

    bioRxiv : the preprint server for biology
    |March 11, 2024
    PubMed
    概括

    在SCN8A性脑病变中,帕瓦胺内部神经元受损,导致大脑抑制减少和发作. 这项研究强调了这些抑制神经元中的SCN8A突变如何导致功能障碍和影响生存.

    更多相关视频

    Preparation of Synaptic Plasma Membrane and Postsynaptic Density Proteins Using a Discontinuous Sucrose Gradient08:06

    Preparation of Synaptic Plasma Membrane and Postsynaptic Density Proteins Using a Discontinuous Sucrose Gradient

    Published on: September 3, 2014

    31.3K
    Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis08:59

    Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

    Published on: July 16, 2021

    2.6K

    相关概念视频

    Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

    Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

    Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
    SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
    296